Introduction:

This survey aims to understand the experiences and unmet needs of people affected by muscle stiffness, tightness and/or involuntary muscle spasms (spasticity) associated with a neurological condition, including Stroke, Multiple Sclerosis, Dystonia and Traumatic Brain Injury.


Additional plain-language explanation:

Throughout this survey, when we use the word “spasticity”, we mean muscle stiffness or tightness and/or muscle spasms that you cannot control. You do not need to have heard the medical term “spasticity” before to complete this survey.

The survey explores when and how spasticity symptoms are recognised; access to information, treatment, rehabilitation and support; experiences of navigating healthcare systems; factors that affect symptoms; and the impact on daily life, work, finances and caregivers. It also explores what could be improved to support earlier recognition and access to appropriate care and support.

This survey is open to neurology patients and caregivers aged 18 and older.

The survey takes approximately 20 minutes to complete.


How your data will be used:

The information you provide will be analysed in an aggregated and anonymised format. The results may be used in reports, policy briefings, awareness campaigns, and other advocacy activities aimed at improving care, services, and quality of life for people living with neurological conditions. Individual responses will never be identifiable in any outputs.


Privacy and data protection:

This survey fully complies with the General Data Protection Regulation (GDPR) and EFNA’s data protection and privacy policies.
No personally identifiable information (such as your name, contact details, or exact location) will be collected. All responses will remain anonymous and confidential. Where there is a free text box, please do not enter identifiable information of others, for example please do not insert names, organisations, hospitals or clinics.

Data will be securely stored and used solely for the purposes described above.


Ethical oversight:


This survey has been reviewed and approved by EFNA’s Ethics Review Board to ensure it meets appropriate ethical and data protection standards.


Voluntary participation:

Your participation is entirely voluntary. You may stop and exit the survey at any time, and your data will not be collected.


Consent statement:

By proceeding to the next page you provide your informed consent to participate in this survey under the conditions described above.

Thank you for your participation in this survey. Your voice matters and will contribute to meaningful change for the neurological community.

Contact, Support and Follow-up:

If you have any queries about this survey, please contact EFNA at Orla.Galvin@efna.net, using “Survey” as the subject line.
For information and support relating to three of the neurological conditions included in this survey, you can contact EFNA’s pan-European member organisations: the European Multiple Sclerosis Platform at emsp.org, Dystonia Europe at dystonia-europe.org, and SAFE – Stroke Alliance for Europe at safe-stroke.eu. To follow the outcomes of this survey, please visit efna.net, subscribe to the EFNA newsletter, or follow EFNA on social media.

T